Business Description
Xlife Sciences AG
ISIN : CH0461929603
Share Class Description:
XLSCF: Ordinary SharesDescription
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | 2.03 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 0.73 | |||||
| Beneish M-Score | 14.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.6 | |||||
| 3-Year EBITDA Growth Rate | -7.3 | |||||
| 3-Year EPS without NRI Growth Rate | -63.6 | |||||
| 3-Year Book Growth Rate | 15.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | |||||
| Quick Ratio | 2.7 | |||||
| Cash Ratio | 0.02 | |||||
| Days Sales Outstanding | 2331.21 | |||||
| Days Payable | 679.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | 1.25 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.55 | |||||
| Operating Margin % | -1885.35 | |||||
| Net Margin % | 2145.05 | |||||
| FCF Margin % | 198.67 | |||||
| ROE % | 8.23 | |||||
| ROA % | 4.25 | |||||
| ROIC % | -5.36 | |||||
| ROC (Joel Greenblatt) % | 328.4 | |||||
| ROCE % | 2.27 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.77 | |||||
| Price-to-Owner-Earnings | 7.96 | |||||
| PS Ratio | 211.85 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Free-Cash-Flow | 109.58 | |||||
| Price-to-Operating-Cash-Flow | 109.58 | |||||
| EV-to-EBIT | 19.54 | |||||
| EV-to-EBITDA | 8.05 | |||||
| EV-to-Revenue | 221.61 | |||||
| EV-to-FCF | 114.68 | |||||
| Earnings Yield (Greenblatt) % | 5.12 | |||||
| FCF Yield % | 1.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:XLSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xlife Sciences AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.132 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 34.8138 | ||
| Shares Outstanding (Mil) | 3.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xlife Sciences AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xlife Sciences AG Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xlife Sciences AG Frequently Asked Questions
What is Xlife Sciences AG(XLSCF)'s stock price today?
The current price of XLSCF is $34.81. The 52 week high of XLSCF is $34.81 and 52 week low is $0.00.
When is next earnings date of Xlife Sciences AG(XLSCF)?
The next earnings date of Xlife Sciences AG(XLSCF) is .
Does Xlife Sciences AG(XLSCF) pay dividends? If so, how much?
Xlife Sciences AG(XLSCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers